SCHEMBL9224569

SCHEMBL9224569

COC1(c2cncc(OCC#Cc3ccccc3)c2)CCOC1C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.48
CHRNB2 P17787 4/20 0.37
CHRNA4 P43681 3/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNB3 Q05901 1/20 0.36
GRM5 P41594 4/20 0.33
EGFR P00533 1/20 0.32
CHRM2 P08172 2/20 0.32
CHRM1 P11229 2/20 0.32
KCNH2 Q12809 1/20 0.31
EGLN1 Q9GZT9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9229172 0.80 ALOX5 (0.71) ALOX5CHRNB2CHRNA4CA12CA1
SCHEMBL9218764 0.76 ALOX5 (0.67) ALOX5GRM5
SCHEMBL9227260 0.75 ALOX5 (0.53) ALOX5CHRNB2CHRNA4CA12CA1
SCHEMBL9365201 0.71 ALOX5 (0.43) ALOX5CHRNB2CHRNA4CA12CA1
SCHEMBL9220205 0.70 SLC6A2 (0.30)
SCHEMBL9370985 0.69 ALOX5 (0.41) ALOX5CHRNB2CHRNA4CA12CA1
SCHEMBL9225871 0.69 ALOX5 (0.54) ALOX5
SCHEMBL9225874 0.69 ALOX5 (0.54) ALOX5
SCHEMBL9227008 0.67 CA12 (0.50) CHRNB2CHRNA4CA12CA1CA2
SCHEMBL9228680 0.67 CHRNB2 (0.38) CHRNB2CHRNA4CHRNB4CHRNA3GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5403859-A PHENYLENE-CYCLIC ETHER COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-04-04 US disclosed
EP-0375404-B1 Heterocyclic derivatives ICI PLC (GB) 1994-02-09 EP disclosed
US-5234950-A Antiallergens, antiinflammatory agents; cardiovascular disorders, antiarthritic IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-08-10 US disclosed
US-5098930-A Inhibitors of lipoxygenase for treatment of diseases mediated with leukotrienes IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-03-24 US disclosed
EP-0375404-A2 Heterocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-27 EP disclosed